Management Change6 Jul 2026, 05:40 pm
Natco Pharma Designates Senior R&D Officials
AI Summary
Natco Pharma Ltd has announced the designation of two key officials, Mr. Gnanadeva Chalapathy Gudipati as Senior Vice President - Analytical Research & Development and Mr. Madhava Rao Karicherla as Vice President – Formulation Research & Development, Pharma Division, Kothur Unit. These designations are effective from July 6, 2026. The filing details their extensive experience and qualifications, highlighting their contributions to the company's research and development capabilities, particularly in complex formulations and analytical methods. Both individuals bring significant experience from previous roles in the pharmaceutical industry.
Key Highlights
- Two senior R&D officials designated with new roles.
- Designations effective July 6, 2026.
- Officials possess extensive experience in R&D and formulation.
- Appointments reflect company's focus on innovation and development.
Price Impact
More from NATCOPHARM